ArticleClinical case reports2025
From Resistance to Relief: IV Levothyroxine in Refractory Hypothyroidism Management.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From Resistance to Relief: IV Levothyroxine in Refractory Hypothyroidism Management.Clinical case reports · 2025Article
- Pseudo-Malabsorption in High Dose Levothyroxine-Resistant Hypothyroidism.JCEM case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report details the clinical scenario of a 27-year-old female patient diagnosed with idiopathic refractory hypothyroidism. Despite adherence to prescribed oral levothyroxine therapy, she continued to experience persistent symptoms such as fatigue and cold intolerance. The exploration of her condition delved into the complexities of refractory hypothyroidism, encompassing both its diagnostic challenges and therapeutic management. A critical distinction was made between true levothyroxine malabsorption and pseudo-malabsorption, the latter being attributed to issues with medication adherence. The scarcity of research on intravenous levothyroxine use in such cases was noted, highlighting the novelty of this approach. The patient's favorable response to intravenous levothyroxine administration, marked by complete symptom resolution and sustained euthyroid state over four years, provides valuable insights. This case contributes significantly to the existing knowledge on the idiopathic etiologies of refractory hypothyroidism and advocates for the consideration of intravenous levothyroxine as an effective alternative when oral administration proves inadequate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.